Hartford Insurance Declares Quarterly Dividend of $0.375 per Depository Share, Payable Feb. 17 to Holders of Record Feb. 2

Hartford Insurance Declares Quarterly Dividend of $0.375 per Depository Share, Payable Feb. 17 to Holders of Record Feb. 2

Keysight Tech | 10-K: FY2025 Revenue Beats Estimate at USD 5.375 B

IQVIA Holdings: Positioned for Growth with Strategic Innovations and Industry Recovery

Analyst Shlomo Rosenbaum from Stifel Nicolaus maintains a Buy rating on IQVIA Holdings, raising the price target to $273.00. The company is poised for growth due to industry recovery, expected revenue growth of 6%-9%, and strategic innovations in AI and Evidence-Based Precision initiatives. Regulatory developments and improved market sentiment further support its growth trajectory. Rosenbaum, a 4-star analyst, highlights IQVIA's strong industry positioning and potential for operational efficiency improvements.

Vaso Diagnostics, Inc. Announces Fifth Extension of Sales Representation Agreement with GE Healthcare

Vaso Diagnostics Inc. has extended its sales representation agreement with GE Healthcare until December 31, 2030. This marks the fifth extension of their collaboration, which began in May 2010, and highlights their commitment to advancing diagnostic imaging and ultrasound solutions in the U.S. VasoHealthcare will continue to represent GE's portfolio, ensuring continuity in sales and alignment with GE's commercial strategy.

Vaso Corp extends sales agreement with GE Healthcare through 2030

Vaso Corp extends sales agreement with GE Healthcare through 2030